DelveInsight's analysis indicates a promising outlook for the dry eye disease market from 2024 to 2034, with positive growth anticipated. This growth trajectory is attributed to the emergence ...

Citing people familiar with the matter, the FT reports that Blackstone is likely to drop out of the ... as well as ophthalmic pharmaceuticals, intraocular lenses, and eye surgery products, and ...

DelveInsight's Dry Eye Disease Market Insights report includes a comprehensive understanding of current treatment practices, ...

Alcon Research LLC lost its court bid Tuesday to veto a public listing by Aurion Biotech Inc., a business it’s backing, but ...

President Trump on Friday vowed to impose sweeping tariffs on semiconductor chips, pharmaceuticals, steel and aluminum and oil and gas. “We’ll be doing pharmaceuticals. Importantly in drugs ...

To get a sense of who is truly in control of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), it is important to understand the ownership structure of the business. With 66% stake, institutions ...

To get a sense of who is truly in control of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), it is important to understand the ownership structure of the business. With 66% stake, institutions possess ...

A slew of recalled OTC eye drops during the past 2 years has diminished patient trust, but optometrists are equipped to restore it.

The main portion of employees (over 60,000) worked in pharmaceuticals – the company's main focus – while the rest are split between Alcon, Sandoz, Vaccines and Diagnostics, Consumer Health ...

Continuous Glucose Monitor Data Predicts Type 1 Diabetes Complications Jan. 15, 2025 — Data from continuous glucose monitors can predict nerve, eye and kidney damage caused by type 1 diabetes ...